Mpox Vaccines and EU's Commitment to Africa CDC

Wednesday, 14 August 2024, 09:00

Mpox vaccines are now on the way, as the EU secures 215,000 doses for the Africa CDC. This significant delivery aims to strengthen health responses across Africa. The MVA-BN® vaccine's procurement follows urgent health priorities set by the European Commission's Health Emergency Preparedness and Response Authority, HERA.
Miragenews
Mpox Vaccines and EU's Commitment to Africa CDC

Mpox Vaccines: EU's Initiative for Africa

The EU is taking critical steps to combat health challenges by securing 215,000 Mpox vaccines for the Africa CDC. The MVA-BN® vaccine is designed to strengthen health responses across the continent. Here are key points about this initiative:

  • 215,000 vaccines from EU procured for Africa CDC
  • Health Emergency Preparedness and Response Authority (HERA) oversees the procurement
  • The move aims to bolster Africa's health defenses against Mpox

Significance of the Vaccination Effort

This vital initiative showcases Europe's commitment to global health and addresses pressing health emergencies directly.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Newsletter

Subscribe to our newsletter for the latest insights and trends from around the world. Stay informed and elevate your global perspective effortlessly.

Subscribe